As part of the team representing the GI SPORE at Dana-Farber/Harvard Cancer Center, Joe presents his work on therapeutic resistance to pre-clinical targeted therapy in Pancreatic Cancer models, including published work on glutaminase inhibitors and unpublished work (supported by a Career Enhancement Program Award from the DF/HCC GI SPORE) on pharmacologic oncogenic KRAS inhibitors. Check out the agenda of the meeting here: GI SPORE Workshop Agenda. Fantastic hosts at the UNMC show us their amazing Chihuly Sanctuary, pictures below!
0 Comments
Lab publishes a review on: The Role of NCOA4-Mediated Ferritinophagy in Health and Disease.10/23/2018
|
Archives
September 2022
Categories |